US Patent 10954529 Minimal volume reprogramming of mononuclear cells
Patent 10954529 was granted and assigned to Fate Therapeutics Inc on March, 2021 by the United States Patent and Trademark Office.
Is a
Date Filed
June 13, 2018
Date of Patent
March 23, 2021
Patent Application Number
16007928
Patent Citations Received
Patent Inventor Names
Bahram Valamehr
0
Peter Flynn
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10954529 Minimal volume reprogramming of mononuclear cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.